Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3706925018 | Substance with interleukin 23 receptor antagonist mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3706926017 | Interleukin 23 receptor antagonist | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Substance with interleukin 23 receptor antagonist mechanism of action (substance) | Is a | Immunologic agent | true | Inferred relationship | Existential restriction modifier | ||
| Substance with interleukin 23 receptor antagonist mechanism of action (substance) | Is a | Substance with interleukin receptor antagonist mechanism of action | true | Inferred relationship | Existential restriction modifier | ||
| Substance with interleukin 23 receptor antagonist mechanism of action (substance) | Has disposition | Interleukin 23 receptor antagonist | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing interleukin 23 receptor antagonist (product) | Has active ingredient | True | Substance with interleukin 23 receptor antagonist mechanism of action (substance) | Inferred relationship | Existential restriction modifier | 1 |
| Tildrakizumab | Is a | True | Substance with interleukin 23 receptor antagonist mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Risankizumab | Is a | True | Substance with interleukin 23 receptor antagonist mechanism of action (substance) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR